TG THERAPEUTICS INC. - COMMON STOCK
17.05
10-5月-24 10:00:06
15 分の遅延
株式
+0.13
+0.77%
本日の幅
16.91 - 17.13
ISIN
N/A
ソース
NASDAQ
-
26 1 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
TG Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
06 1 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy)
28 12 2022 13:48:07 提供 Nasdaq GlobeNewswire
-
TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
10 11 2022 07:30:01 提供 Nasdaq GlobeNewswire
-
TG Therapeutics to Host Conference Call on Third Quarter 2022 Financial Results and Business Update
08 11 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
TG Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
09 9 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
25 8 2022 07:30:47 提供 Nasdaq GlobeNewswire
-
TG Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
08 8 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
TG Therapeutics to Host Conference Call on Second Quarter 2022 Financial Results and Business Update
05 8 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
TG Therapeutics Announces FDA Extension of BLA PDUFA Date for Ublituximab to Treat Patients with RMS
31 5 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
TG Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
20 5 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
26 4 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
15 4 2022 08:30:00 提供 Nasdaq GlobeNewswire